アリヴェクシス㈱
4 known investors
Alivexis is a drug discovery company developing small-molecule targeted therapeutics by combining biology research with a computational technology platform. It operates as an international team with pharmaceutical, biotechnology, and computational R&D experience.
Investors · 4
Competitors · 4
by search overlap
Exelixis14 shared keywordsExelixis is an oncology company that discovers and develops cancer treatments, including small molecule therapeutics and biotherapeutics such as antibody-drug conjugates, for patients across multiple tumor types. Its flagship commercial product is CABOMETYX (cabozantinib), and it operates through global development and commercialization partnerships.
Bioworld11 shared keywordsBioWorld is a suite of daily news and data services covering therapeutics, medical technology, biopharma business transactions, and drug R&D, serving biopharmaceutical and medtech industry professionals. Owned by Clarivate, it publishes products including BioWorld, BioWorld Science, and BioWorld Asia with reporting from writers stationed globally.
Scynexis10 shared keywordsSCYNEXIS develops fungerp-based antifungal therapies, including SCY-247, for treating and preventing severe, progressive, and often fatal fungal diseases and antimicrobial-resistant infections. The company focuses on rare diseases affecting underserved patient populations.
Alumis9 shared keywordsAlumis is a clinical-stage biopharmaceutical company developing a late-stage portfolio of targeted therapies for immune-mediated diseases. It focuses on small-molecule drug discovery and development in immunology and inflammation.
Companies competing with アリヴェクシス㈱ for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does アリヴェクシス㈱ do?
- Alivexis is a drug discovery company developing small-molecule targeted therapeutics by combining biology research with a computational technology platform. It operates as an international team with pharmaceutical, biotechnology, and computational R&D experience.
- Who are アリヴェクシス㈱'s investors?
- アリヴェクシス㈱'s investors include DBJ Capital, Fast Track Initiative, Mobile Internet Capital, Inc., UTokyo Innovation Platform Co. Ltd..